Samsun University
Samsun, Turkey (Türkiye)
NCT Number: NCT06508177
Regional anesthesia and analgesia technics are widely and securely used during general surgery procedures. Interfascial plane blocks are the latest used ones for analgesia. There are studies in literature indicating that bupivacaine cause myotoxicity. The investigators aimed to examine plasma creatine phosphokinase (CPK) levels to see whether myotoxicity occurs or not after fascial plane blocks are applied to patients undergoing laparoscopic cholecystectomy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Samsun, Turkey (Türkiye)
During 3 months period all elligible patients undergoing laparoscopic cholecystectomy surgery will be included in the study. Different postoperative analgesic modalities will be used according to the anesthesists experience. During routine blood sample tests plasma creatin phosphokinase (CPK) levels will be tested 3 times of all patients(preoperative, postoperative 6th hour, postoperative 24th hour). Data will be analysed and patients will be grouped according to the analgesic modalities used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interfascial plane blocks will be added to the routine analgesia plan as part of multimodal analgesia.
This is the routine analgesia plan applied in our clinic.
Time frame: at postoperative 24th hour
Serum creatine phosphokinase levels at 24th hour
Samsun University
Other
Does Postoperative Analgesic Modalities Effect Blood Creatin Phosphokinase Levels After Laparoscopic Cholecystectomy Surgery?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05505890
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04821245
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Seattle, Washington, United States
View Trial DetailsNCT00199745
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Oslo, Norway
View Trial DetailsNCT07633587
Cardiomyopathies, Cardiovascular Diseases
Paris, France
View Trial Details